Familial Prostate Cancer Latest Advances

Artificial Intelligence Across the PSMA Theranostic Continuum in Prostate Cancer.

Journal: PET clinics

Published: April 12, 2026

Identifying preferences for prostate cancer screening among American Indian men (Project AIMEPCCo): Protocol for a discrete choice experiment.

Journal: JMIR research protocols

Published: April 10, 2026

Clinical and Reader Associated Correlates of Clinically Significant MRI-Invisible Prostate Cancer based on Negative MRI.

Journal: The Journal of urology

Published: March 23, 2026

Radiotheranostics in solid tumors: focus on radiopharmaceutical therapy and clinical challenges.

Journal: Expert review of anticancer therapy

Published: March 19, 2026

Detecting Distant Metastases in Prostate Cancer Using Whole-body MR Imaging Together with DWIBS (Diffusion-weighted Imaging with Background Body Signal Suppression).

Journal: Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine

Published: March 18, 2026

Is Standard TRUS-Guided Prostate Biopsy the End of the Game?

Journal: Urology research & practice

Published: March 13, 2026

Real-world experience with PSMA-PET in primary staging and biochemical recurrence settings: data from the Michigan Urological Surgery Improvement Collaborative.

Journal: Urology practice

Published: March 12, 2026

Association of Family History and Polygenic Risk Scores With Prostate Cancer in Africa.

Journal: JCO global oncology

Published: March 11, 2026

BRCA1/2 and CHEK2 Pathogenic Variants in Urological Cancers: A Portuguese Single-Center Experience.

Journal: Cureus

Published: March 10, 2026

Familial Risks in 317 000 Patients With Prostate Cancer in Relation to Metastases and Survival-Guiding Diagnostics.

Journal: European urology open science

Published: March 06, 2026

Reduced Rate of Complications With Transperineal Prostate Biopsy: Real-world Data From a National Cohort Derived From the Danish Prostate Cancer Registry.

Journal: European urology open science

Published: March 05, 2026

Quantification of olaparib in human liver microsomes using an ultra-fast UPLC-MS/MS quantitative approach: in vitro and in silico metabolic stability assessment.

Journal: The Analyst

Published: March 05, 2026

Familial Prostate Cancer Latest Advances

Find the Latest Research About Familial Prostate Cancer

Artificial Intelligence Across the PSMA Theranostic Continuum in Prostate Cancer.

Artificial Intelligence Across the PSMA Theranostic Continuum in Prostate Cancer.

Identifying preferences for prostate cancer screening among American Indian men (Project AIMEPCCo): Protocol for a discrete choice experiment.

Identifying preferences for prostate cancer screening among American Indian men (Project AIMEPCCo): Protocol for a discrete choice experiment.

Clinical and Reader Associated Correlates of Clinically Significant MRI-Invisible Prostate Cancer based on Negative MRI.

Clinical and Reader Associated Correlates of Clinically Significant MRI-Invisible Prostate Cancer based on Negative MRI.

Radiotheranostics in solid tumors: focus on radiopharmaceutical therapy and clinical challenges.

Radiotheranostics in solid tumors: focus on radiopharmaceutical therapy and clinical challenges.

Detecting Distant Metastases in Prostate Cancer Using Whole-body MR Imaging Together with DWIBS (Diffusion-weighted Imaging with Background Body Signal Suppression).

Detecting Distant Metastases in Prostate Cancer Using Whole-body MR Imaging Together with DWIBS (Diffusion-weighted Imaging with Background Body Signal Suppression).

Is Standard TRUS-Guided Prostate Biopsy the End of the Game?

Is Standard TRUS-Guided Prostate Biopsy the End of the Game?

Real-world experience with PSMA-PET in primary staging and biochemical recurrence settings: data from the Michigan Urological Surgery Improvement Collaborative.

Real-world experience with PSMA-PET in primary staging and biochemical recurrence settings: data from the Michigan Urological Surgery Improvement Collaborative.

Association of Family History and Polygenic Risk Scores With Prostate Cancer in Africa.

Association of Family History and Polygenic Risk Scores With Prostate Cancer in Africa.

BRCA1/2 and CHEK2 Pathogenic Variants in Urological Cancers: A Portuguese Single-Center Experience.

BRCA1/2 and CHEK2 Pathogenic Variants in Urological Cancers: A Portuguese Single-Center Experience.

Familial Risks in 317 000 Patients With Prostate Cancer in Relation to Metastases and Survival-Guiding Diagnostics.

Familial Risks in 317 000 Patients With Prostate Cancer in Relation to Metastases and Survival-Guiding Diagnostics.

Reduced Rate of Complications With Transperineal Prostate Biopsy: Real-world Data From a National Cohort Derived From the Danish Prostate Cancer Registry.

Reduced Rate of Complications With Transperineal Prostate Biopsy: Real-world Data From a National Cohort Derived From the Danish Prostate Cancer Registry.

Quantification of olaparib in human liver microsomes using an ultra-fast UPLC-MS/MS quantitative approach: in vitro and in silico metabolic stability assessment.

Quantification of olaparib in human liver microsomes using an ultra-fast UPLC-MS/MS quantitative approach: in vitro and in silico metabolic stability assessment.